资源中心

A mitochondria-targeted nanomedicine for myocardial ischemia/reperfusion injury with synergistic antioxidant and anti-inflammatory properties.

发布时间：

1970-01-01

Li C, Zhang Z, Luo C, Lan W, Liu C, Liu W, Xiang H, Yang J, Tang Y, Wang X. A mitochondria-targeted nanomedicine for myocardial ischemia/reperfusion injury with synergistic antioxidant and anti-inflammatory properties. J Nanobiotechnology. 2025 Nov 5;23(1):705. doi: 10.1186/s12951-025-03810-3.

上一个

Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy

无

下一个

上一个：

Magnoflorine attenuates Ang II-induced cardiac remodeling via promoting AMPK-regulated autophagy

下一个：

无

活动中心

α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure

1970-01-01

BAF155 promotes cardiac hypertrophy and fibrosis through inhibition of WWP2-mediated PARP1 ubiquitination

1970-01-01

Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction

1970-01-01

Ultrasound-triggered microbubble destruction enhances the radiosensitivity of glioblastoma by inhibiting PGRMC1-mediated autophagy in vitro and in vivo

1970-01-01

Treatment of infarcted heart tissue via the capture and local delivery of circulating exosomes through antibody-conjugated magnetic nanoparticles

1970-01-01

Construction of tissue-engineered vascular grafts with enhanced patency by integrating heparin, cell-adhesive peptide, and carbon monoxide nanogenerators into acellular blood vessels

1970-01-01

分享到

返回列表